The surface expression of ACE2 is reduced in SARS-CoV infections due to the spike protein internalization followed by ACE2 lysosomal degradation [20] and because the shed soluble form of ACE2 (sACE2) lacks the membrane anchor and circulates in small amounts in the blood [21]. Here, ACE2 is linked to severe acute respiratory syndrome.